Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.65 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.60 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.57 |
| ▸ | TUBB | P07437 | 1/20 | 0.57 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.57 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.57 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.57 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.57 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.57 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.57 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.57 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.57 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.57 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.57 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.57 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.57 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15882450 | 0.85 | TUBB4A (0.72) | CYP1B1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL15882451 | 0.85 | TUBB4A (0.72) | CYP1B1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL3666809 | 0.82 | USP2 (0.58) | CYP1B1CYP1A1CYP1A2TUBB4ATUBB | |
| SCHEMBL658670 | 0.81 | PFKFB3 (0.70) | CYP1B1CYP1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL658669 | 0.81 | PFKFB3 (0.70) | CYP1B1CYP1A1CYP1A2CYP3A4CYP2D6 | |
| Wr-190433 SCHEMBL6180067 | 0.80 | TUBB4A (0.66) | CYP1B1CYP3A4TUBB4ATUBBTUBA3C | |
| Wr-190433 SCHEMBL977482 | 0.80 | TUBB4A (0.66) | CYP1B1CYP3A4TUBB4ATUBBTUBA3C | |
| Wr-190433 SCHEMBL30880222 | 0.80 | TUBB4A (0.66) | CYP1B1CYP3A4TUBB4ATUBBTUBA3C | |
| Wr-190433 SCHEMBL29870441 | 0.80 | TUBB4A (0.66) | CYP1B1CYP3A4TUBB4ATUBBTUBA3C | |
| SCHEMBL1604279 | 0.80 | TUBB4A (0.65) | CYP1B1CYP3A4TUBB4ATUBBTUBA3C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2246351-B1 | COMPOUND HAVING PYRIDOINDOLE RING STRUCTURE BONDED WITH SUBSTITUTED PYRIDYL GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO LTD (JP) | 2015-05-06 | — | — | EP | disclosed |
| US-8624228-B2 | Compound having pyridoindole ring structure bonded with substituted pyridyl group, and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2014-01-07 | — | — | US | disclosed |
| US-20100308322-A1 | COMPOUND HAVING PYRIDOINDOLE RING STRUCTURE BONDED WITH SUBSTITUTED PYRIDYL GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE | Hodogaya Chemical Co,. Ltd. (JP) | 2010-12-09 | — | — | US | disclosed |
| EP-2246351-A1 | COMPOUND HAVING PYRIDOINDOLE RING STRUCTURE BONDED WITH SUBSTITUTED PYRIDYL GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE | Hodogaya Chemical Co., Ltd. (JP) | 2010-11-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100308322-A1 | COMPOUND HAVING PYRIDOINDOLE RING STRUCTURE BONDED WITH SUBSTITUTED PYRIDYL GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE | KCNH3, KCNH2, PRDM9 | CYP1B1 684/4885CYP1A1 507/4885CYP1A2 1225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.